Shares of Lam Research Corporation (NASDAQ:LRCX – Get Free Report) traded up 3.8% during mid-day trading on Wednesday . The company traded as high as $240.34 and last traded at $235.12. 9,346,947 shares were traded during mid-day trading, a decline of 31% from the average session volume of 13,643,743 shares. The stock had previously closed at $226.61.
Wall Street Analyst Weigh In
LRCX has been the topic of a number of research analyst reports. Argus boosted their target price on Lam Research from $175.00 to $280.00 in a research note on Tuesday, February 3rd. HSBC boosted their price objective on Lam Research from $181.00 to $221.00 and gave the stock a “hold” rating in a research report on Friday, January 30th. Barclays set a $250.00 target price on Lam Research in a research report on Thursday, January 29th. Citigroup boosted their price target on shares of Lam Research from $265.00 to $300.00 and gave the stock a “buy” rating in a report on Thursday, January 29th. Finally, Summit Insights upgraded shares of Lam Research from a “hold” rating to a “buy” rating in a research report on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus target price of $244.88.
Check Out Our Latest Research Report on Lam Research
Lam Research Stock Up 3.8%
Lam Research (NASDAQ:LRCX – Get Free Report) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The business had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.Lam Research’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.
Lam Research Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Wednesday, March 4th. Lam Research’s dividend payout ratio (DPR) is currently 21.31%.
Insiders Place Their Bets
In other Lam Research news, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the transaction, the director owned 253,705 shares in the company, valued at $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the sale, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.31% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the business. PMV Capital Advisers LLC acquired a new position in Lam Research during the fourth quarter worth $25,000. IMG Wealth Management Inc. bought a new stake in Lam Research during the second quarter worth approximately $26,000. Stance Capital LLC acquired a new position in Lam Research during the third quarter valued at approximately $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research in the second quarter valued at approximately $27,000. Finally, Triumph Capital Management acquired a new stake in shares of Lam Research in the third quarter worth $27,000. Institutional investors and hedge funds own 84.61% of the company’s stock.
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
- Five stocks we like better than Lam Research
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
